Head-to-head
Noom Med vs NovoCare Pharmacy (Wegovy)
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Noom Med is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Noom Med is $199 a month all-in for semaglutide; NovoCare Pharmacy (Wegovy) is $349. Over twelve months that is $2,388 against $4,188. Value Scores are 73.1 and 45.9 out of 100.
Semaglutide
Plan pages: Noom Med plans · NovoCare Pharmacy (Wegovy) plans
At 2.4 mg/week, Noom Med is $199 a month all-in and NovoCare Pharmacy (Wegovy) is $349 — $150 apart, or $1,800 across a year. Over twelve months the totals are $2,388 (billed monthly) and $4,188 (billed monthly).
Noom Med charges a flat $199 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
NovoCare Pharmacy (Wegovy) charges a flat $349 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Noom Med | Rank | NovoCare Pharmacy (Wegovy) | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $199 | 17/32 | $349 | 31/32 | Noom Med by $150 |
| 0.5 mg | $199 | 12/21 | $349 | 21/21 | Noom Med by $150 |
| 1 mg | $199 | 12/21 | $349 | 21/21 | Noom Med by $150 |
| 1.7 mg | $199 | 12/21 | $349 | 21/21 | Noom Med by $150 |
| 2.4 mg | $199 | 14/29 | $349 | 27/29 | Noom Med by $150 |
Noom Med is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Noom Med sits 10 of 29 on all-in monthly cost and NovoCare Pharmacy (Wegovy) sits 26. There are 15 other programs priced between them. The field median is $249 and the floor is $129, so Noom Med is below the median and the other is above it. Noom Med is $70 above the cheapest semaglutide program on record. NovoCare Pharmacy (Wegovy) is $220 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Noom Med undercuts it by $150, NovoCare Pharmacy (Wegovy) by $0. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Noom Med | NovoCare Pharmacy (Wegovy) | Cheaper |
|---|---|---|---|
| Month to month | $199 | $349 | Noom Med by $150 |
| Settled dose | Noom Med | NovoCare Pharmacy (Wegovy) | Difference |
|---|---|---|---|
| 0.25 mg | $2,388 | $4,188 | $1,800 apart |
| 0.5 mg | $2,388 | $4,188 | $1,800 apart |
| 1 mg | $2,388 | $4,188 | $1,800 apart |
| 1.7 mg | $2,388 | $4,188 | $1,800 apart |
| 2.4 mg | $2,388 | $4,188 | $1,800 apart |
Noom Med publishes no rate for 3-month term, 6-month term, 12-month term; NovoCare Pharmacy (Wegovy) publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $2,388 on Noom Med and $4,188 on NovoCare Pharmacy (Wegovy). The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 73.1 for Noom Med and 45.9 for NovoCare Pharmacy (Wegovy), against a semaglutide category floor of $129. Noom Med leads by 27.2 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Noom Med | 45.4 | 12.8 | 10 | 5 | 73.1 |
| NovoCare Pharmacy (Wegovy) | 25.9 | 15.0 | 0 | 5 | 45.9 |
Where the two programs differ
All-in monthly
Noom Med is cheaper month to month — $199 against $349, a gap of $150 every month, or $1,800 across a year if both rates hold.
Cancellation terms
Cancellation differs: Noom Med states Per plan terms, while NovoCare Pharmacy (Wegovy) states No subscription lock. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Noom Med asks for Program-based; NovoCare Pharmacy (Wegovy) asks for None. This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Noom Med charges one price at every dose; NovoCare Pharmacy (Wegovy) prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Noom Med's figure is provider-stated and NovoCare Pharmacy (Wegovy)'s is verified. NovoCare Pharmacy (Wegovy) rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $2,388 for Noom Med and $4,188 for NovoCare Pharmacy (Wegovy). Noom Med is lower by $1,800 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Noom Med Official site
Noom bundles its behavior program with medication access; compounded semaglutide lists at $199/month all-in.
It names its compounding pharmacy — Partner pharmacies, recorded as Partner network — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Program-based; cancellation is Per plan terms; availability is stated as Most US states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — noom.com program page capture 2026-08-08
Watch: Noom's program bundling changes frequently; confirm what the quoted figure includes.
NovoCare Pharmacy (Wegovy) Official site
Novo Nordisk's direct cash pharmacy sells FDA-approved Wegovy pens at $349/month across standard doses ($399 for the 7.2 mg HD pen), with a $199 introductory price on the first two starter-dose fills and oral Wegovy tablets from $149/month. It is the FDA-approved semaglutide price floor and the benchmark for every compounded semaglutide quote.
It names its compounding pharmacy — CoAssist Pharmacy d/b/a NovoCare Pharmacy, recorded as Manufacturer direct — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are None; cancellation is No subscription lock; availability is stated as 50 states.
Evidence: verified — captured at checkout by our desk on the stated date, captured . Source — novocare.com price guide and savings-offer pages, retrieved 2026-08-11
Watch: The $199 intro and the $149 oral tier both carry published expiration dates; the durable numbers are $349 pen / $399 HD.
Which molecules each one carries
Noom Med carries semaglutide at $199 a month; does not offer tirzepatide.
NovoCare Pharmacy (Wegovy) carries semaglutide at $349 a month; does not offer tirzepatide.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Noom Med does not publish
- no published twelve-month semaglutide rate
- no state-by-state availability list — it says Most US states
- no specific cancellation or refund terms
NovoCare Pharmacy (Wegovy) does not publish
- no published twelve-month semaglutide rate
Ask Noom Med and NovoCare Pharmacy (Wegovy) for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Noom Med Official site wins this matchup. If you expect to titrate to the top of the ladder, noom med's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, novocare pharmacy (wegovy)'s price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Noom Med's semaglutide price is provider-stated as of 2026-08-08; NovoCare Pharmacy (Wegovy)'s is verified as of 2026-08-11.
Questions
Is Noom Med or NovoCare Pharmacy (Wegovy) cheaper for semaglutide?
Noom Med is cheaper on all-in monthly cost at 2.4 mg/week: $199 against $349, a difference of $150 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Noom Med versus NovoCare Pharmacy (Wegovy)?
Noom Med works out to $2,388 across twelve months and NovoCare Pharmacy (Wegovy) to $4,188, on the plan terms each publishes.
Does Noom Med or NovoCare Pharmacy (Wegovy) raise the price as the dose goes up?
Noom Med: no, it charges one flat rate at every dose. NovoCare Pharmacy (Wegovy): yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Noom Med and NovoCare Pharmacy (Wegovy) differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Noom Med and NovoCare Pharmacy (Wegovy) names its pharmacy?
Both do. Noom Med names Partner pharmacies and NovoCare Pharmacy (Wegovy) names CoAssist Pharmacy d/b/a NovoCare Pharmacy, so both can be checked against state board licensing and FDA inspection records.
How well evidenced are the Noom Med and NovoCare Pharmacy (Wegovy) prices?
Noom Med's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. NovoCare Pharmacy (Wegovy)'s is verified, captured 2026-08-11. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Noom Med official site · NovoCare Pharmacy (Wegovy) official site. Compounded tirzepatide and semaglutide are not FDA-approved products.